Ajit Mahadevan told The Economic Times of India that credit restrictions will see biotechs increasingly turn to India. This will help drive growth from its current $200m a year, to the $600m that KPMG predicted it would reach by 2010.
Breaking News on Contract Research, Manufacturing & Clinical Trials
Headlines > Clinical Development
News in brief
Biotech may turn to Indian for clinical trials
25-Nov-2008
Related topics: Clinical Development
The Indian clinical trials market is predicted to continue its growth despite the current financial climate, according to a partner at Ernst & Young India’s Healthsciences Practice.
Latest news in Contract Manufacturing
Copyright - Unless otherwise stated all contents of this web site are © 2000/2010 - Decision News Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department: Administration & Finance - Full details for the use of materials on this site can be found in the Terms & Conditions
Related site
All Decision News Media Sites
Food & Beverage: Nutrition: Pharmaceutical: Cosmetics:
Partners | Events | About us | Site map | All sites | Recommend this Site | Advertise | Contact the Editor | Terms & Conditions | Privacy Policy
©; 2000/2010 - Decision News Media SAS - All right reserved.
